ECSP16069947A - Formulaciones tópicas de heparina - Google Patents

Formulaciones tópicas de heparina

Info

Publication number
ECSP16069947A
ECSP16069947A ECIEPI201669947A ECPI201669947A ECSP16069947A EC SP16069947 A ECSP16069947 A EC SP16069947A EC IEPI201669947 A ECIEPI201669947 A EC IEPI201669947A EC PI201669947 A ECPI201669947 A EC PI201669947A EC SP16069947 A ECSP16069947 A EC SP16069947A
Authority
EC
Ecuador
Prior art keywords
present
formulations
topical
heparin formulations
topical heparin
Prior art date
Application number
ECIEPI201669947A
Other languages
English (en)
Inventor
Prakash J Shah
M R Patel
A K Patel
K R Patel
Original Assignee
Troikaa Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52684592&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP16069947(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Troikaa Pharmaceuticals Ltd filed Critical Troikaa Pharmaceuticals Ltd
Publication of ECSP16069947A publication Critical patent/ECSP16069947A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se relaciona con formulaciones tópicas avanzadas de sales farmacéuticamente aceptables de Heparina que proporcionan penetración transdérmica mejorada. La presente invención proporciona formulaciones líquidas, no pegajosas, claras en las que el fármaco está listo para absorción y que son adecuadas para administración en la forma de una solución o una pulverización. Las formulaciones tópicas de la presente invención no forman película con escamas o similar a gel sobre la superficie de la piel luego de aplicación tópica.
ECIEPI201669947A 2014-02-10 2016-08-26 Formulaciones tópicas de heparina ECSP16069947A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN475MU2014 2014-02-10

Publications (1)

Publication Number Publication Date
ECSP16069947A true ECSP16069947A (es) 2018-06-30

Family

ID=52684592

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI201669947A ECSP16069947A (es) 2014-02-10 2016-08-26 Formulaciones tópicas de heparina

Country Status (25)

Country Link
US (1) US9861655B2 (es)
EP (1) EP3104839B1 (es)
JP (1) JP6275877B2 (es)
KR (1) KR101822133B1 (es)
CN (1) CN106163498A (es)
AP (1) AP2016009350A0 (es)
AR (1) AR099333A1 (es)
AU (1) AU2015213569B2 (es)
CA (1) CA2938388C (es)
CL (1) CL2016001952A1 (es)
CU (1) CU24444B1 (es)
DK (1) DK3104839T3 (es)
DO (1) DOP2016000198A (es)
EA (1) EA032200B1 (es)
EC (1) ECSP16069947A (es)
IL (1) IL246974B (es)
MA (1) MA39304B1 (es)
MX (1) MX357765B (es)
MY (1) MY182620A (es)
NZ (1) NZ722830A (es)
PE (1) PE20161173A1 (es)
PH (1) PH12016501500A1 (es)
TW (1) TWI538697B (es)
UA (1) UA118279C2 (es)
WO (1) WO2015118512A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011130455A1 (en) * 2010-04-13 2011-10-20 Najib Babul Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use
CN112546061B (zh) * 2021-02-25 2021-06-11 中南大学湘雅医院 一种肝素类药物组合物、喷鼻剂及其制备方法及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3323389A1 (de) * 1983-06-29 1985-01-10 B. Braun Melsungen Ag, 3508 Melsungen Auf schleimhaeute des mundes, der nase und/oder des rachens wirkende arzneimittel auf der basis von heparin und tensiden
JPH02207018A (ja) * 1989-02-07 1990-08-16 Kao Corp 皮膚外用剤
DE19536244A1 (de) 1994-09-30 1996-04-04 Juergen Dr Regenold Pharmazeutische Zusammensetzung zur lokalen Applikation
IT1275955B1 (it) 1995-03-22 1997-10-24 Dompe Spa Formulazioni farmaceutiche in forma di gel tissotropico
JPH10279466A (ja) * 1997-04-07 1998-10-20 Kose Corp 外用剤
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
BRPI0101486B1 (pt) 2001-04-17 2017-09-19 Cristália Produtos Químicos Farmacêuticos Ltda. Pharmaceutical composition for topic use containing heparin for the treatment of skin or mucosal injuries caused by burns
RU2467759C2 (ru) * 2006-11-15 2012-11-27 Артрайтис Рилиф Плас Лтд Состав для местного использования и его применения
IT1400232B1 (it) * 2010-05-07 2013-05-24 Advance Holdings Ltd Composizione farmaceutica topica comprendente eparina
RU2013147883A (ru) * 2011-04-01 2015-05-10 Юниверсити Оф Флорида Рисеч Фаундэйшн, Инк. Термочувствительные, мукоадгезивные или кожно-адгезивные и усиливающие проникновение композиции для местной доставки терапевтических средств

Also Published As

Publication number Publication date
TWI538697B (zh) 2016-06-21
TW201532631A (zh) 2015-09-01
CU20160119A7 (es) 2016-10-28
MX357765B (es) 2018-07-23
IL246974B (en) 2018-07-31
CU24444B1 (es) 2019-10-04
MA39304B1 (fr) 2018-12-31
AR099333A1 (es) 2016-07-13
KR101822133B1 (ko) 2018-01-25
PH12016501500B1 (en) 2017-02-06
KR20160117529A (ko) 2016-10-10
DK3104839T3 (da) 2020-01-20
DOP2016000198A (es) 2016-10-31
PH12016501500A1 (en) 2017-02-06
UA118279C2 (uk) 2018-12-26
US9861655B2 (en) 2018-01-09
CA2938388A1 (en) 2015-08-13
WO2015118512A1 (en) 2015-08-13
EP3104839B1 (en) 2019-11-13
EA201691596A1 (ru) 2017-01-30
AP2016009350A0 (en) 2016-07-31
CN106163498A (zh) 2016-11-23
CA2938388C (en) 2018-07-17
MX2016010399A (es) 2017-02-23
MY182620A (en) 2021-01-27
JP2017505344A (ja) 2017-02-16
EP3104839A1 (en) 2016-12-21
AU2015213569A1 (en) 2016-08-18
AU2015213569B2 (en) 2018-01-04
EA032200B1 (ru) 2019-04-30
MA39304A1 (fr) 2018-01-31
NZ722830A (en) 2018-01-26
JP6275877B2 (ja) 2018-02-07
US20170165291A1 (en) 2017-06-15
CL2016001952A1 (es) 2017-03-10
PE20161173A1 (es) 2016-10-27

Similar Documents

Publication Publication Date Title
DK3273942T3 (da) Mikronåleplaster til indgivelse af en aktiv bestanddel til huden
EP3622947B8 (en) Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
MX2018001723A (es) Conjugados farmaco-multiligando y usos de los mismos.
SV2015005115A (es) Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades
MX391858B (es) Compuestos terapeuticamente activos y sus metodos de uso
MX384073B (es) Una composicion farmaceutica para reducir la grasa localizada y sus usos.
MX2016000121A (es) Tratamiento de lesiones inflamatorias de rosacea con invermectina.
AR096402A1 (es) Medicamento de metformina y dihidroquercetina
CR20150360A (es) Sistema de liberación transdérmica
MX2018000166A (es) Metodos para una mejor administración de agentes activos a tumores.
MX2016013236A (es) Formulacion inmunosupresora.
MX2015009045A (es) Composiciones y metodos para tratar el dolor severo.
BR112015030315A2 (pt) derivado de 4-alquinilimidazol e medicamento compreendendo o mesmo como ingrediente ativo
CL2017000845A1 (es) Inhibidores de gingipaina de lisina
DOP2016000297A (es) Composiciones farmacéuticas útiles para tratar enfermedades infecciosas
PE20150721A1 (es) Composicion farmaceutica que comprende gemigliptina y metformina, y metodo para su preparacion
ECSP16086247A (es) (s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicina
CL2017001773A1 (es) Análogos de calcitonina para tratar enfermedades y trastornos.
MX2016011025A (es) Composiciones de grapiprant y metodos para usar las mismas.
ECSP16069947A (es) Formulaciones tópicas de heparina
CL2016000397A1 (es) Tratamiento contra el cáncer
ECSP16086232A (es) (r) -pirlindole y sus sales farmacéuticamente aceptables para uso en medicina
CL2018001797A1 (es) Formulación galénica que comprende un fármaco tópico
EA201501130A1 (ru) Офтальмологическая фармацевтическая композиция
MX2019009909A (es) Composiciones farmaceuticas para terapia de combinacion.